FNY Partners Fund’s AtriCure ATRC Stock Holding History

FNY Partners Fund’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,500	Closed	-$47K	–	593
2017 Q1	$47K	Buy	+2,500	New	+$43.8K	0.01%	735

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FNY Partners Fund's ATRC Position: Q2 2017 in Review

FNY Partners Fund sold out of AtriCure (ATRC) in Q2 2017, closing a stake of 2,500 shares — an estimated $47K sold.

FNY Partners Fund first reported a position in ATRC in Q1 2017 and held it in 1 quarter. The position peaked at $47K in Q1 2017. 107 funds tracked by Wall St. Rank hold ATRC as of Q2 2017.

FNY Partners Fund reported no remaining AtriCure position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 2,500 AtriCure shares in Q2 2017, an estimated $47K.
FNY Partners Fund first reported a position in AtriCure in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's AtriCure position peaked at $47K in Q1 2017.
107 funds tracked by Wall St. Rank held AtriCure as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.